New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia-Reference-Cited by-同舟云学术

New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia

Published:2022-01 Issue:1 Volume:18 Page:177-188
ISSN:1551-7136
Container-title:Heart Failure Clinics
language:en
Short-container-title:Heart Failure Clinics

Author:

Cesaro Arturo,Fimiani Fabio,Gragnano Felice,Moscarella Elisabetta,Schiavo Alessandra,Vergara Andrea,Akioyamen Leo,D’Erasmo Laura,Averna Maurizio,Arca Marcello,Calabrò Paolo^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference69 articles.

1. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur Heart J,2014

2. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

3. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome;Sjouke;Eur Heart J,2015

4. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review;Austin;Am J Epidemiol,2004

5. Homozygous autosomal dominant hypercholesterolaemia;Sjouke;Curr Opin Lipidol,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA);Nutrition, Metabolism and Cardiovascular Diseases;2024-08

2. Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery;Biomaterials;2024-07

3. The Beneficial Effect of Lomitapide on the Cardiovascular System in LDLr−/− Mice with Obesity;Antioxidants;2023-06-16

4. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance;European Heart Journal;2023-05-02

5. Lipid-lowering therapy in patients with coronary artery disease undergoing percutaneous coronary interventions in Italy: an expert opinion paper of Interventional Cardiology Working Group of Italian Society of Cardiology;Journal of Cardiovascular Medicine;2023-04